IL18 and tuberculosis: Alternatively, anti-inflammatory treatment for TB-IRIS as well as severe COVID-19 could evaluate the possible role of IL-18 inhibition based on the central role of IL-18 in the immunopathogenesis of both these conditions and preliminary findings [125,129].